Fundamental Data for ARXT

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.

# Employees: 0

Address: ,,,

Phone:

Fax:

Website:

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

No Information

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2007

Next Earnings Date(Expected): 2/6/2008

Mean EPS (Next Qtr): $0.32

Mean EPS (Year): $1.73

Mean Estimate(Long Term): $30.00

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 5

Shares Performance

Period	ARXT	Compare to S&P
YTD	-0.01 %	10.81 %
4 Weeks	-0.01 %	-0.01 %
12 Weeks	-0.01 %	-0.01 %

Shares Information

Analyst Coverage: Y

Avg Volume: 1180014

Shares Outstanding: 36M

Market Cap: ($0.01)M

52 Week High: $60.01

52 Week Low: $28.22

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 ARXT split by factor of 0.200

Earnings Performance

EPS Growth in Last Quarter: 2,733.33 %

EPS Growth in Last Year: 29.51 %

Sales Growth in Last Quarter: 134.69 %

Sales Growth in Last Quarter: 22.00 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010